Regulation of the lower urinary tract: urination and urinary incontinence

Q Pharmacology, Toxicology and Pharmaceutics Anales De La Real Academia Nacional De Farmacia Pub Date : 2022-12-31 DOI:10.53519/analesranf.2022.88.05.14
Albino García Sacristán
{"title":"Regulation of the lower urinary tract: urination and urinary incontinence","authors":"Albino García Sacristán","doi":"10.53519/analesranf.2022.88.05.14","DOIUrl":null,"url":null,"abstract":"Urinary incontinence represents a serious social, medical and economic problem, which suffers a progressive increase, due to the increase in life expectancy that social, health and cultural advances have achieved. It is estimated that in the world there are approximately two hundred million people in urinary incontinence with a great economic impact of great importance that can exceed the coverage forecasts of the different systems of health care services. Our group from the Department of Physiology of the UCM has been studying the physiology of the lower urinary tract (LUT) for several years in order to determine the neurotransmitters and receptors that regulate these structures. This greater knowledge of the Physiology and Pathophysiology of the LUT has allowed these dysfunctions to be corrected with pharmacological methods compared to the traditional alternative of surgery. Keywords: micturition; urinary incontinence; chemical neurotransmission; neurotransmitters; receptors","PeriodicalId":50795,"journal":{"name":"Anales De La Real Academia Nacional De Farmacia","volume":" ","pages":""},"PeriodicalIF":0.0000,"publicationDate":"2022-12-31","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":"0","resultStr":null,"platform":"Semanticscholar","paperid":null,"PeriodicalName":"Anales De La Real Academia Nacional De Farmacia","FirstCategoryId":"1085","ListUrlMain":"https://doi.org/10.53519/analesranf.2022.88.05.14","RegionNum":0,"RegionCategory":null,"ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":null,"EPubDate":"","PubModel":"","JCR":"Q","JCRName":"Pharmacology, Toxicology and Pharmaceutics","Score":null,"Total":0}
引用次数: 0

Abstract

Urinary incontinence represents a serious social, medical and economic problem, which suffers a progressive increase, due to the increase in life expectancy that social, health and cultural advances have achieved. It is estimated that in the world there are approximately two hundred million people in urinary incontinence with a great economic impact of great importance that can exceed the coverage forecasts of the different systems of health care services. Our group from the Department of Physiology of the UCM has been studying the physiology of the lower urinary tract (LUT) for several years in order to determine the neurotransmitters and receptors that regulate these structures. This greater knowledge of the Physiology and Pathophysiology of the LUT has allowed these dysfunctions to be corrected with pharmacological methods compared to the traditional alternative of surgery. Keywords: micturition; urinary incontinence; chemical neurotransmission; neurotransmitters; receptors
查看原文
分享 分享
微信好友 朋友圈 QQ好友 复制链接
本刊更多论文
下尿路的调节:排尿和尿失禁
尿失禁是一个严重的社会、医疗和经济问题,由于社会、健康和文化进步所带来的预期寿命延长,这一问题日益严重。据估计,世界上大约有2亿人患有尿失禁,其经济影响非常重要,可能超过不同卫生保健服务系统的覆盖范围预测。我们来自UCM生理学系的团队已经研究下尿路(LUT)的生理学好几年了,以确定调节这些结构的神经递质和受体。与传统的外科手术相比,对LUT生理学和病理生理学的更深入了解使得这些功能障碍可以通过药理学方法得到纠正。关键词:排尿;尿失禁;化学神经传递;神经递质;受体
本文章由计算机程序翻译,如有差异,请以英文原文为准。
求助全文
约1分钟内获得全文 去求助
来源期刊
CiteScore
0.13
自引率
0.00%
发文量
7
期刊介绍: The Anales de la Real Academia Nacional de Farmacia� embraces all aspects of pharmaceutical sciences and is a quarterly journal that publishes basic and applied research on pharmaceutical sciences and related areas. It is a medium for reporting selected original and significant contributions to new pharmaceutical knowledge.
期刊最新文献
Therapeutic repositioning: importance of new therapeutic indications approved for old medicines The mRNA COVID 19 vaccine: More than a drug? Detection and management of a case of drug-resistant hypertension Galenic development of a capsule containing rosuvastatin, repaglinide, and olmesartan mini-tablets for the treatment of metabolic syndrome Novel drugs recently authorized by ema and fda (Q2, 2024)
×
引用
GB/T 7714-2015
复制
MLA
复制
APA
复制
导出至
BibTeX EndNote RefMan NoteFirst NoteExpress
×
×
提示
您的信息不完整,为了账户安全,请先补充。
现在去补充
×
提示
您因"违规操作"
具体请查看互助需知
我知道了
×
提示
现在去查看 取消
×
提示
确定
0
微信
客服QQ
Book学术公众号 扫码关注我们
反馈
×
意见反馈
请填写您的意见或建议
请填写您的手机或邮箱
已复制链接
已复制链接
快去分享给好友吧!
我知道了
×
扫码分享
扫码分享
Book学术官方微信
Book学术文献互助
Book学术文献互助群
群 号:481959085
Book学术
文献互助 智能选刊 最新文献 互助须知 联系我们:info@booksci.cn
Book学术提供免费学术资源搜索服务,方便国内外学者检索中英文文献。致力于提供最便捷和优质的服务体验。
Copyright © 2023 Book学术 All rights reserved.
ghs 京公网安备 11010802042870号 京ICP备2023020795号-1